Assessing a research peptide supplier does not require advanced chemical knowledge, only the application of verifiable criteria. Six concrete questions separate a supplier that documents what it sells from one that merely asserts it.
Which criteria allow a supplier to be assessed?
Assessment does not depend on advanced chemical knowledge. It depends on whether the supplier can answer six questions with documents rather than assertions.
| Criterion | Concrete question | Insufficient answer |
|---|---|---|
| Laboratory | Which laboratory issues the certificates and can it be contacted independently? | "Certified laboratory" with no name. |
| Traceability | Does the certificate correspond to the exact batch of the delivered vial? | A generic sample certificate. |
| Scope | Is material arriving in the country verified, or only what leaves the factory? | Origin certificate only. |
| Raw data | Does the certificate include chromatogram and spectrum? | Only a final percentage. |
| Rejection policy | What threshold is required and what happens to a failing batch? | No declared criterion. |
| Regulatory framework | Is it openly declared that the product is research grade? | Attribution of therapeutic effects. |
Why is batch traceability the decisive criterion?
Because it is the only one linking a document to a physical object. A certificate describes a batch analysed on a date. If the document code does not match the one printed on the received vial, the certificate describes different material.
The practical test is simple and unambiguous: request the certificate for the specific batch to be delivered, not an example. A supplier that documents its batches provides it without difficulty. One publishing a generic figure cannot, because the specific document does not exist.
Why does the purity figure not differentiate suppliers?
Because practically all declare equivalent values. In a review of the Colombian research peptide market, the vast majority of sites declare purity above 99% without identifying any laboratory.
When every player publishes the same figure and none supports it, the datum loses discriminating power. What differentiates is documentary support, not the number. A verifiable 99% carries more information than a 99.9% declared without evidence.
What distinguishes the scope of verification?
Three clearly distinguishable levels exist, and the difference between them is substantive.
- ✓Level 1, declaration: the supplier asserts a purity figure with no supporting document.
- ✓Level 2, origin certificate: presents the manufacturer COA, issued by an identifiable laboratory, on the produced batch.
- ✓Level 3, destination verification: adds an independent analysis of material actually arriving in the country.
The step from level 1 to 2 matters most, because it introduces a verifiable document where only an assertion existed. The step from 2 to 3 closes the distance between certified batch and delivered product, as detailed in the article on double verification.
Why ask about the rejection policy?
Because it is the question distinguishing a control from a formality. A verification scheme that has never rejected a batch is not acting as a filter.
A supplier with real control can answer three things: what threshold it requires, what procedure applies when a batch fails, and whether that situation has arisen. Discomfort with this question is usually informative in itself.
What does the description of the regulatory framework reveal?
A serious supplier declares that the product is research grade, holds no INVIMA registration and is not intended for medical, diagnostic or therapeutic use.
Anyone attributing therapeutic effects to a research-grade product, or suggesting it holds health approval for human use, is misdescribing what they sell. That imprecision matters beyond the legal question: whoever does not describe their product's framework accurately is unlikely to describe its quality accurately.
What does market track record add?
A supplier with history has previous batches to show and a documentary chain that can be audited backwards. A newly formed one has no such record, regardless of intentions.
Track record does not replace documentation, but it allows verifying that the declared scheme has been applied consistently rather than being a statement of intent.
Verification checklist
Questions to ask before a purchase
- Can the certificate of analysis for the specific batch to be dispatched be provided?
- Which laboratory issues it and how is it contacted independently?
- Does the certificate include an HPLC chromatogram and mass spectrum, or only a figure?
- Does the document batch number match the one printed on the vial?
- Is material received in the country verified, or only what leaves the factory?
- What purity threshold is required and what happens to a batch that fails it?
- Is the research-grade framework explicitly declared?
These criteria apply to any supplier, including the publisher of this article. The verification process applied at Vital Boost is described on the purity verification page, which also offers free review of certificates of analysis issued to third parties.
References
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3-55. PMID: 18604941.
- Domon B, Aebersold R. Mass spectrometry and protein analysis. Science. 2006;312(5771):212-217. DOI: 10.1126/science.1124619.
- Manning MC, Chou DK, Murphy BM, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. DOI: 10.1007/s11095-009-0045-6.
